Cargando…

Diagnostic, Prognostic, and Therapeutic Use of Radiopharmaceuticals in the Context of SARS-CoV-2

[Image: see text] The coronavirus disease 2019 (COVID-19) outbreak has devastated the healthcare systems and economies of over 200 countries in just a few months. The etiological agent of COVID-19, SARS-CoV-2, is a highly contagious virus that can be transmitted by asymptomatic and symptomatic carri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pallares, Roger M., Abergel, Rebecca J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839413/ https://www.ncbi.nlm.nih.gov/pubmed/33615159 http://dx.doi.org/10.1021/acsptsci.0c00186

Ejemplares similares

Development of radiopharmaceuticals for targeted alpha therapy: Where do we stand?
por: Pallares, Roger M., et al.
Publicado: (2022)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Domnanich, Katharina, et al.
Publicado: (2014)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Airaksinen, A, et al.
Publicado: (2016)

Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Dorrer, H, et al.
Publicado: (2011)

Aptamers—Diagnostic and Therapeutic Solution in SARS-CoV-2
por: Wandtke, Tomasz, et al.
Publicado: (2022)

Insight into prognostics, diagnostics, and management strategies for SARS CoV-2
por: Amara, Umay, et al.
Publicado: (2022)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Koester, Ulli, et al.
Publicado: (2018)

IS528 Novel diagnostic and therapeutic radionuclides for the development of innovative radiopharmaceuticals
por: Köster, Ulli
Publicado: (2017)

SARS-CoV-2: diagnostic and design conundrums in the context of male factor infertility
por: Bahadur, Gulam, et al.
Publicado: (2020)

SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge
por: Ezhilan, Madeshwari, et al.
Publicado: (2021)

Cancer and SARS-CoV-2 Infection: Diagnostic and Therapeutic Challenges
por: Allegra, Alessandro, et al.
Publicado: (2020)

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa
por: Margolin, Emmanuel, et al.
Publicado: (2020)

SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines
por: Thakur, Suresh, et al.
Publicado: (2022)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

Present therapeutic and diagnostic approaches for SARS-CoV-2 infection
por: Gupta, Sayan Dutta, et al.
Publicado: (2022)

Hydroxypyridinones as a Very Promising Platform for Targeted Diagnostic and Therapeutic Radiopharmaceuticals
por: Zhou, Xu, et al.
Publicado: (2021)

Developing scandium and yttrium coordination chemistry to advance theranostic radiopharmaceuticals
por: Carter, Korey P., et al.
Publicado: (2020)

Therapeutic Radiopharmaceuticals Targeting Integrin αvβ6
por: Färber, Stefanie Felicitas, et al.
Publicado: (2018)

An Exploration of Nanoparticle-Based Diagnostic Approaches for Coronaviruses: SARS-CoV-2, SARS-CoV and MERS-CoV
por: Al-Hindawi, Ahmed, et al.
Publicado: (2022)

Quantum tunnelling in the context of SARS-CoV-2 infection
por: Adams, Betony, et al.
Publicado: (2022)

Dosing Therapeutic Radiopharmaceuticals in Obese Patients
por: van Nuland, Merel, et al.
Publicado: (2022)

Carbon-based nanomaterials against SARS-CoV-2: Therapeutic and diagnostic applications
por: Ahmadi, Sepideh, et al.
Publicado: (2023)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, E. P., et al.
Publicado: (2020)

The flexibility of ACE2 in the context of SARS-CoV-2 infection
por: Barros, Emilia P., et al.
Publicado: (2021)

Review of Adverse Reactions Associated with the Use of Common Diagnostic Radiopharmaceuticals
por: Meher, Bikash Ranjan, et al.
Publicado: (2021)

Possible fates of the spread of SARS-CoV-2 in the Mexican context
por: Santamaría-Holek, I., et al.
Publicado: (2020)

Lifetime of sessile saliva droplets in the context of SARS-CoV-2
por: Balusamy, Saravanan, et al.
Publicado: (2021)

Surveillance for SARS‐CoV‐2 variants of concern in the Australian context
por: Andersson, Patiyan, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in the context of original antigenic sin
por: Petráš, Marek, et al.
Publicado: (2021)

Diagnostic Salivary Tests for SARS-CoV-2
por: Azzi, L., et al.
Publicado: (2020)

The Interpretation of SARS-CoV-2 Diagnostic Tests
por: Stites, Edward C., et al.
Publicado: (2020)

Pitfalls in SARS‐CoV‐2 PCR diagnostics
por: Wernike, Kerstin, et al.
Publicado: (2020)

SARS-CoV-2 detection with CRISPR diagnostics
por: Guo, Lu, et al.
Publicado: (2020)

Diagnostic Testing for SARS-CoV-2 Infection
por: Thomas, Emmanuel, et al.
Publicado: (2021)

Solidifying diagnostics in SARS-CoV-2 research
por: Cimolai, Nevio
Publicado: (2022)

Rapid Diagnostic Testing for SARS-CoV-2
por: Drain, Paul K.
Publicado: (2022)

SARS-CoV-2 Molecular Diagnostics in China
por: Lu, Yanjun, et al.
Publicado: (2022)

Cytokine Profiles as Potential Prognostic and Therapeutic Markers in SARS-CoV-2-Induced ARDS
por: Salton, Francesco, et al.
Publicado: (2022)

SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2
por: Halder, Sayanti, et al.
Publicado: (2023)

Evaluation of SARS-CoV-2 diagnostics and risk factors associated with SARS-CoV-2 infection in Zambia()
por: Tembo, John, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ivqpd092qccbaj9ebgt7hq7pvi